GT Metabolic Solutions

GT Metabolic Solutions is a Minneapolis-based medical device company developing magnetic compression technology for creating gastrointestinal anastomoses. Its incisionless, sutureless and reversible platform supports endoscopic, robotic and laparoscopic surgical access and is expanding into new surgical and therapeutic settings.

  • Series C+
  • Biotechnology
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Oct 28, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Oct 28, 2026

    Series C+

    Led by J.P. Morgan Life Sciences Private Capital

    • J.P. Morgan Life Sciences Private Capital

    Article coming soon.

Pricing

Research GT Metabolic Solutions — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if GT Metabolic Solutions is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational